首页 > 医疗资讯/ 正文
欧洲人类生殖与胚胎学学会(ESHRE)年会是生殖医学领域规模最大、最具影响力的年度国际学术会议之一,覆盖生殖医学领域所有专业。2023年ESHRE年会已经召开,生殖医学论坛精选了众多会议精华内容进行了翻译,希望给大家带来最新鲜、最前沿的生殖医学资讯。
本篇内容由翻译志愿者吕莉医生翻译,蔡贺博士审校,供大家学习交流!
Study question
研究问题
Among patients undergoing ovarian stimulation for ICSI, does dual trigger with hCG and GnRH agonist offer any benefit over mono trigger with hCG alone?
在卵巢刺激后行ICSI的患者中,绒促性素(HCG)配伍促性腺激素释放激素激动剂(GnRHa)双扳机是否优于HCG单扳机。
Summary answer
结论总结
Dual trigger is associated with a higher number of mature oocytes without any impact on the pregnancy rate.
双扳机与更多的卵泡数相关,但并不影响妊娠率。
What is known already
既往已知
In ART cycles, final oocyte maturation and resumption of meiosis are generally triggered by the administration of hCG as a surrogate for the natural LH surge. Several studies have investigated the role of a combination of a bolus of GnRH agonists and hCG to mimic the natural peak of endogenous LH and FSH, without clear answers regarding clinical benefit. A meta-analysis showed highernumbers of good-quality embryos and increased ongoing pregnancy rate after dual trigger and a recent systematic review demonstrated significantly higher live birth rate (LBR) per cycle after administration of dual trigger compared to hCG-only trigger.
在辅助生殖技术(ART)周期中,常用HCG替代自然周期中LH峰,促发卵泡的最后成熟和启动减数分裂。有多项研究,旨在阐明GnRHa配伍HCG模拟自然周期中内源性的FSH和LH峰的作用,但在临床受益方面尚无明确结果。一项荟萃分析显示双扳机可获得更多的优质胚胎,持续妊娠率也增加。最近的一项系统回顾指出,与HCG单扳机相比,双扳机明显提高了每周期的活产率。
Study design, size, duration
研究设计、规模、时长
The study was a retrospective, single-centre cohort study. In this study, 8,525 ICSI cycles were included between January 2017 and April 2022 at a tertiary referral University Hospital. We included all patients undergoing ICSI in a GnRH antagonist ovarian stimulation cycle. The mono trigger consisted of recombinant or highly purified urinary hCG. In the dual trigger group, a bolus of GnRH agonist was combined with the hCG trigger.
此研究为回顾性、单中心队列研究。本研究共纳入2017年1月至2022年4月一家大学附属三级医院的8525个周期。纳入患者均在拮抗剂周期后行单精子胞浆内注射(ICSI)。单扳机组使用重组或高纯化尿HCG。双扳机组使用单剂GnRHa和HCG。
Participants/materials, setting, methods
研究对象/材料、设定、方法
Our cohort of 8,525 cycles was divided into two groups: Group A, the mono trigger group, (7,022 cycles), and Group B, the dual trigger group (1503 cycles). Patients who underwent IVF, pre-implantation genetic testing, oocyte donation, and fertility preservation were excluded. Patients with uterine anomalies and endocrine disorders were also excluded, as well as patients who received a triptorelin-only trigger because of hyperresponse.
将8525个周期分为两组:组A:单扳机组(7022个周期);组B:双扳机组(1503个周期)。行体外受精(IVF)、植入前基因诊断、供卵、生育力保存的患者除外。子宫异常、内分泌疾病以及因卵巢高反应而单用曲普瑞林扳机的患者除外。
Main results and the role of chance
主要结果及几率
There was no difference in the mean age between the dual vs mono trigger cohorts (35.93 ± 4.90 vs 35.52±4.85). The most common indication for ART was male factor infertility in both groups (21.36% in group B vs 27.11% in group A). Stimulation was shorter in the dual trigger cohort (10.41 vs 12.08 p = 0.04). The total number of cumulus oocyte complexes (8.26±5.32 vs 7.45±4.68, p < 0.001), mature oocytes (6.39±4.15 vs 5.99±3.80, p = 0.006) and fertilized oocytes (4.79±3.59 vs 4.33±3.27, p = <0.001) was higher in the dual trigger group compared to those in the mono trigger group. Day 5 embryo transfer was more prevalent in the dual trigger group (46.07% vs 33,84%, p < 0.001). Embryo utilization rate was higher in group A (61.37% ±31.98) than in group B (53.47% ±30.91 p = <0.001). Ongoing regnancy rate was similar in both groups (27.29% in group A vs 27.08% in group B). Pearson chi2, Mann Whitney and logistic regression tests were used for the analysis.
两组患者的平均年龄无差异(35.93±4.90 vs 35.52±4.85)。两组中行ART最常见的指征为男性因素不孕(21.36% 组B vs 27.11% 组A)。双扳机队列中卵巢刺激周期较短(10.41 vs 12.08 p=0.04)。双扳机组获卵数(8.26±5.32 vs 7.45±4.68,p<0.001),成熟卵母细胞数(6.39±4.15 vs 5.99±3.80,p=0.006)、受精卵数(4.79±3.59 vs 4.33±3.27,p=<0.001)均高于单扳机组。双扳机组第五天胚胎移植率更高(46.07% vs 33.84%,p<0.001)。单扳机组胚胎利用率更高(单扳机组61.37%±31.98%;双扳机组53.47%±30.91% p=<0.001)。两组持续妊娠率相似(单扳机组 27.29% vs 双扳机组 27.08%)。数据分析采用卡方检验,Mann-Whitney逻辑回归。
Limitations, reasons for caution
局限性
In spite of the large sample, this study is retrospective and holds the possibility of unmeasured confounders.
尽管样本数量较大,但本研究为回顾性研究,可能包含不可测定的混杂因素。
Wider implications of the findings
研究结果的深层意义
Although a dual trigger may increase the number of mature oocytes, this does not translate into a higher pregnancy nor live birth rate. Reduced oocyte competence of the “surplus” oocytes may underlie this observation. Further research should identify specific subgroups that may benefit from dual trigger across meaningful outcome parameters.
尽管双扳机可能增加成熟卵泡数量,但并不因此意味着妊娠率或活产率的增加。这项研究可能是建立在“过剩”的卵泡数量会降低卵母细胞的功能的基础上的。进一步的研究应针对从有意义的结果参数中,确定从双扳机中受益的特殊亚群。
文章来源:C Blockeel, M P Agius, S De Rijdt, H Tournaye, M De Vos, P Drakopoulos, O-294 Dual trigger versus hCG-only trigger in ICSI patients: an analysis of 8500 cycles, Human Reproduction, Volume 38, Issue Supplement_1, June 2023, dead093.358, https://doi.org/10.1093/humrep/dead093.358
- 搜索
-
- 1000℃Cell | 曾泽贤/潘登/冯驭团队开发SPAC-seq新技术,实现空间分辨率下高通量CRISPR筛选
- 1000℃福建师范大学ACS Nano:人工智能驱动的Janus敷料用于可视化伤口诊疗
- 1000℃中科院苏州纳米所ACS Nano综述:通过可穿戴AI接口学习人类-环境交互
- 1000℃Cancer Discov | 新型AI基础模型可根据基因型精准预测癌症治疗反应,涵盖10种实体瘤超3万个肿瘤基因组数据
- 1000℃新加坡国立大学/复旦大学《自然·通讯》:抗氧化脂质纳米颗粒增强mRNA稳定性用于再生治疗和基因编辑
- 1000℃489例疑似罕见遗传病患者进行全外显子测序WES:确诊率达53%,5.5%检出心血管或肿瘤相关基因变异
- 1000℃Nat Cancer | 基于组织病理学图像的AI模型可快速识别102种CNS肿瘤亚型,表现优于神经病理学家
- 1000℃国立清华大学《自然·通讯》:工程化人类PEG10纳米颗粒实现RNA自包装、递送与癌症治疗
- 精J Child Psychol Psychiatry:12种罕见神经发育障碍儿童沟通能力谱系
- 精研究发现:爱吃辣的人,心血管病和癌症死亡风险都会显著降低
- 精Nursing in Critical Care:别再指责护士了!ICU 里被遗漏的护理,根源在系统而非个人
- 精Acta Obstet Gynecol Scand:罕见病女性的妊娠并发症与母婴结局,一项单中心434种罕见病的回顾性队列研究
- 精【爱儿小醉】儿科患者术前对流层臭氧暴露与围手术期呼吸系统不良事件之间的关系:一项单中心回顾性队列研究
- 精eBioMedicine:牙龈下微生物组与脑健康存在连续关联梯度,牙周炎或成认知衰退可干预靶点
- 精军事医学研究院《自然·通讯》:自适应IrPtCu纳米酶水凝胶实现耐药菌感染伤口序贯治疗
- 精能够逆转萎缩性胃炎的两个中成药,该怎么选择?
- 荐Lancet子刊:国产CRVIAAI精准识别胰腺癌血管侵犯,准确率超越资深影像专家
- 荐Pharmacol Res:胃癌耐药的 "双重密码",细胞因子与表观遗传的异常对话
- 荐新一代ICU体系:德尔格持续升级整体解决方案能力,实现更智能、安静、高效的诊疗环境!
- 荐论文解读│经由多组学视角更新法布雷病重要靶器官病理生理机制
- 荐【醉翁之艺】小胶质细胞激活通过CXCL10介导的CD8+T细胞募集促进衰老相关白质退化
- 荐《柳叶刀》重磅:奥瑞珠单抗显著延缓原发进展型多发性硬化老年及重度残疾患者进展
- 荐STTT:派安普利单抗联合化疗为复发转移性鼻咽癌带来持久生存获益
- 荐ASCO 2026:中国领衔LIBRETTO-432研究,塞普替尼引领RET融合阳性非小细胞肺癌早期治疗新突破,降低83%的疾病复发或死亡风险
- 标签列表
-
- 星座 (702)
- 孩子 (526)
- 恋爱 (505)
- 婴儿车 (390)
- 宝宝 (328)
- 狮子座 (313)
- 金牛座 (313)
- 摩羯座 (302)
- 白羊座 (301)
- 天蝎座 (294)
- 巨蟹座 (289)
- 双子座 (289)
- 处女座 (285)
- 天秤座 (276)
- 双鱼座 (268)
- 婴儿 (265)
- 水瓶座 (260)
- 射手座 (239)
- 不完美妈妈 (173)
- 跳槽那些事儿 (168)
- baby (140)
- 女婴 (132)
- 生肖 (129)
- 女儿 (129)
- 民警 (127)
- 狮子 (105)
- NBA (101)
- 家长 (97)
- 怀孕 (95)
- 儿童 (93)
- 交警 (89)
- 孕妇 (77)
- 儿子 (75)
- Angelababy (74)
- 父母 (74)
- 幼儿园 (73)
- 医院 (69)
- 童车 (66)
- 女子 (60)
- 郑州 (58)